Big Pharma's Executive Brain Drain Benefits Biotech
This article was originally published in Start Up
Executive Summary
Big Pharma has provided its executives with unrivaled stability, opportunity, and financial rewards, but swelling numbers are fleeing corporate offices for tiny biotechs. A blip in good times for biotech or a sea change for the industry?